Sakar Healthcare Ltd. NSE: SAKAR

Sakar Healthcare Ltd. Live Share Price Today, Share Analysis and Chart

Name: Sakar Healthcare Ltd.: Is Infosys Ltd. worth buying?
Item: Sakar Healthcare Ltd.
Rating: 3.423916625
Author: Trendlyne DVM scores

Strong Performer, Getting Expensive

about

Sakar Healthcare is engaged in manufacturing of Pharmaceutical products providing Liquid Orals, Cephalosporin Tablet, Capsule, Dry Powder Syrup, Dry Powder Injections, Liquid Injectable (SVP) in Ampoules,Vials & Lyophilized Injections, Oral Solid Dos...

364.00 0.70 (0.19%)

Near 52W High of ₹380.80

10,980

NSE Volume

NSE 09 Oct, 2025 12:13 PM (IST)

Loading... You have run out of DVM views! Check usage

Subscribe now to see details

High Financial Strength

80.0 / 100

Mid Valuation

43.8 / 100

Technically Bullish

70.1 / 100

Strong Performer, Getting Expensive These stocks are strong in quality and technical aspects but with medium valuation. Due to expensive valuation it is suggested that opportunity to be observed before buying. View Similar Embed DVM

No estimates available

Sakar Healthcare Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Is Sakar Healthcare Ltd. worth buying?

40 Votes:

Buy 87.5%

Sell 5.0%

Hold 7.5%

Sakar Healthcare Ltd. Live Share Price Today, Share Analysis and Chart

Sakar Healthcare is engaged in manufacturing of Pharmaceutical products providing Liquid Orals, Cephalosporin Tablet, Capsule, Dry Powder Syrup, Dry Powder Injections, Liquid Injectable (SVP) in Ampoules,Vials & Lyophilized Injections, Oral Solid Dos...

Near 52W High of ₹380.80

SWOT Analysis

Sakar Healthcare Live Price Chart